Security key
M47238148
Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)
CUSIP: M47238148
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares, NIS 1.80 par value per share
- Total 13F shares
- 5,585
- Total 13F value
- $38,313
- Share change
- +5,584
- SEC-reported price per share
- $6.86
- Number of holders
- 9
- Value change
- +$38,306
- Number of buys
- 8
- Shares outstanding
- 5,591,387
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
9
Top holders
9
GLMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Galmed Pharmaceuticals Ltd. SEC filings
Galmed Pharmaceuticals Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M47238148
Recent filing periods:
Ownership snapshot
Top reported holders of GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Walleye Capital LLC
Disclosed value leader
Walleye Capital LLC
Comparable rows
0/11
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $83,110
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Walleye Capital LLC has the largest disclosed position value at $83.1K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Walleye Capital LLC's linked filing trail.
Disclosed position value
Top 5
Walleye Capital LLC
$83.1K
CVI Holdings, LLC
$13.5K
MORGAN STANLEY
$10K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$3.3K
TWO SIGMA SECURITIES, LLC
$2.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Walleye Capital LLC |
13F
Company
|
—
class O/S missing
|
$83,110
290,596 shares
|
— | 30 Jun 2024 |
| CVI Holdings, LLC |
13F
Company
|
—
class O/S missing
|
$13,510
47,239 shares
|
— | 30 Jun 2024 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$9,959
36,213 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
class O/S missing
|
$3,325
11,625 shares
|
— | 30 Jun 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
class O/S missing
|
$2,841
10,330 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$77
280 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
5,585
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q1 2026 Across Filers
Q1 2026 holders
14
Q3 2024 holders
9
Holder diff
-5
| Investor | Q1 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend